Lv1
20 积分 2023-08-20 加入
Case report outcome of cetuximab treatment in a metastatic colorectal cancer patient with novel KRAS P34R
3小时前
已完结
Case report outcome of cetuximab treatment in a metastatic colorectal cancer patient with novel KRAS P34R
1天前
求助中
The evolving panorama of HER2-targeted treatments in metastatic urothelial cancer: A systematic review and future perspectives
21天前
已完结
Umbilical cord and wound treatment
21天前
已关闭
TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes
21天前
已完结
EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma
21天前
已完结
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
22天前
已完结
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
23天前
已完结
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
23天前
已完结
皖公网安备34019202002308
